17 patents currently held
1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Sep 2032. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Sep 2032
Next term end
8
Patent families
When these terms end
Held patents by the year their term ends
notable patents
all others
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Jul 2033 · High confidence
Also notable
Ends Sep 2035 · High confidence
Also notable
Ends Jan 2039 · High confidence
Systems and Methods for Visualizing Ablated Tissue
US 9,084,611
The most cited patent in this portfolio, cited by 113 later US patents, top 5% of utility patents granted in 2015 in our data. Protection runs to 2033.
Systems and Methods for Determining Lesion Depth Using Fluorescence Imaging
US 11,096,584
Cited by 38 later US patents, top 5% of utility patents granted in 2021 in our data. Protection runs to 2035.
Systems and Methods for Lesion Formation and Assessment
US 10,779,904
Cited by 43 later US patents, top 5% of utility patents granted in 2020 in our data. Protection runs to 2039.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jan 21, 2027The maintenance fee for Systems and Methods for Visualizing Ablated Tissue (US 9,084,611) comes due Jan 21, 2027. Unpaid by Jul 21, 2027, it lapses early.
Recent changes
- 2 of the patents on this record were granted since Aug 20, 2026
What they patent
The 5 largest of its 8 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Systems and Methods for Visualizing Ablated Tissue | 6 in force | to Jul 2033 |
| Systems and Methods for Assessment of Contact Quality | 3 in force | to Jan 2037 |
| Systems and Methods for Lesion Formation and Assessment | 2 in force | to Jan 2039 |
| Systems and Methods for Lesion Assessment | 2 in force | to Dec 2036 |
| Systems and Methods for Optimizing Tissue Ablation | 1 in force | to Apr 2045 |
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,076,238 | Systems and Methods for Visualizing Ablated Tissue In force · High confidence | In force | High confidence | |
| US 10,716,462 | Systems and Methods for Visualizing Ablated Tissue In force · High confidence | In force | High confidence | |
| US 11,559,192 | Systems and Methods for Visualizing Ablated Tissue In force · High confidence | In force | High confidence | |
| US 12,075,980 | Systems and Methods for Visualizing Ablated Tissue In force · Medium confidence | In force | Medium confidence | |
| US 12,653,389 | Systems and Methods for Visualizing Ablated Tissue In force · Medium confidence | In force | Medium confidence | |
| US 9,084,611 | Systems and Methods for Visualizing Ablated Tissue In force · High confidence | In force | High confidence | |
| US 11,096,584 | Systems and Methods for Determining Lesion Depth Using Fluorescence Imaging In force · High confidence | In force | High confidence | |
| US 10,682,179 | Systems and Methods for Determining Tissue Type In force · High confidence | In force | High confidence | |
| US 11,596,472 | Systems and Methods for Assessment of Contact Quality In force · Low confidence | In force | Low confidence | |
| US 12,295,795 | Systems and Methods for Lesion Formation and Assessment In force · High confidence | In force | High confidence |
Also on record, not counted in the 17: 1 patent in force now held by others · 1 application pending · 1 application abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.